Clinical Trial Update: Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

View source ↗

Summary

Roche-sponsored clinical trial update on HER-2 status in gastric and gastroesophageal junction cancers; the study is completed and results were posted on 2016-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Status: COMPLETED | Results posted: 2016-10-28